MarketCapTrends
BMRN

Biomarin Pharmaceutical Inc. (BMRN)

NASDAQ · Healthcare
Total AssetsCash on HandLong Term DebtTotal LiabilitiesShareholder Equity

Biomarin Pharmaceutical Inc. annual/quarterly shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Biomarin Pharmaceutical Inc. shareholder equity for the quarter ending December 31, 2025 were 6.09B, a 7.58% increase year-over-year.
  • Biomarin Pharmaceutical Inc. shareholder equity for 2025 were 6.09B, a 7.58% increase from 2024.
  • Biomarin Pharmaceutical Inc. shareholder equity for 2024 were 5.66B, a 14.27% increase from 2023.
  • Biomarin Pharmaceutical Inc. shareholder equity for 2023 were 4.95B, a 7.57% increase from 2022.
  • Biomarin Pharmaceutical Inc. shareholder equity for 2022 were 4.60B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Biomarin Pharmaceutical Inc. Annual Shareholder Equity (Millions of US $)
2025$6,087
2024$5,658
2023$4,952
2022$4,603
2021$4,266
2020$4,101
2019$3,122
2018$2,968
2017$2,809
2016$2,766
2015$2,401
2014$1,528
2013$1,341
2012$1,016
2011$773
Biomarin Pharmaceutical Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$6,087
2024-12-31$5,658
2023-12-31$4,952
2022-12-31$4,603
2021-12-31$4,266
2020-12-31$4,101
2019-12-31$3,122
2018-12-31$2,968
2017-12-31$2,809
2016-12-31$2,766
2015-12-31$2,401
2014-12-31$1,528
2013-12-31$1,341
2012-12-31$1,016
2011-12-31$773
2010-12-31$717
2009-12-31$322

Biomarin Pharmaceutical Inc. Shareholder Equity — FAQ

Biomarin Pharmaceutical Inc. (BMRN) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BMRN's shareholder equity history?

The chart and table above show Biomarin Pharmaceutical Inc.'s shareholder equity by year and by quarter, including the growth rate.